Cell strain | Subtype, origin | External genitalia/ phenotype | Age at biopsy (years; months) | Androgen receptor |
N-33 | GSF, foreskin | Normal fertile male | 51;11 | Normal (Kd 0.08 nM, Bmax 26.40 fmol/mg protein) |
N-40 | GSF, foreskin | Normal male | 7;11 | Normal (Kd 0.09 nM, Bmax 32.44 fmol/mg protein) |
N-52 | GSF, foreskin | Normal male | 0;3 | Normal (Kd 0.06 nM, Bmax 35.36 fmol/mg protein) |
N-56 | GSF, foreskin | Normal fertile male | 42;10 | Normal (Kd 0.07 nM, Bmax 13.35 fmol/mg protein) |
N-57 | GSF, foreskin | Normal male | 5;11 | Normal (Kd 0.05 nM, Bmax 24.13 fmol/mg protein) |
N-58 | GSF, foreskin | Normal male | 5;11 | Normal (Kd 0.10 nM, Bmax 30.61 fmol/mg protein) |
N-59 | GSF, foreskin | Normal male | 0;8 | Normal (Kd 0.07 nM, Bmax 40.01 fmol/mg protein) |
N-60 | GSF, foreskin | Normal male | 5;4 | Normal (Kd 0.05 nM, Bmax 20.08 fmol/mg protein) |
N-62 | GSF, foreskin | Normal male | 2;0 | Normal (Kd 0.08 nM, Bmax 86.16 fmol/mg protein) |
N-AKPZF | PRF, peripheral zone | Normal male | Adult | Not investigated |
N-ST4 | ASF, abdominal skin | Normal male | 46;0 | Not investigated |
N-LS12 | FSF, forearm skin | Normal male | 36;0 | Not investigated |
ARD1097 | GSF, labia majora | Normal female | 1;3 | CAIS, Pro390Ser + Arg855Gly, negative androgen binding |
ARD411 | GSF, labia majora | Normal female | 0;4 | CAIS, Arg855Cys, negative androgen binding |
ARD682 | GSF, labia majora | Normal female | 14;10 | CAIS, no mutation in AR-gene, negative androgen binding, no AR-protein in western immunoblot |
ARD402 | GSF, labia majora | Normal female | 1;0 | CAIS, no mutation in AR-gene, negative androgen binding, very low AR-mRNA transcription, no AR-protein in western immunoblot |
ARD377 | GSF, labia majora | Predominantly female | 1;2 | AIS4, Ile841Ser, (Kd 0.55 nM; Bmax 17.01 fmol/mg protein) |
ARD842 | GOF, gonad | Normal female | 38;0 | CAIS, 26 bp deletion exon 1 (141-150), frameshift, premature stop codon, negative androgen binding |
ARD1004 | GOF, gonad | Normal female | 17;4 | CAIS, Val866Met, negative androgen binding |
ARD291 | GOF, gonad | Normal female | 18;4 | CAIS, Phe794Ser, negative amdrogen binding |
ARD531 | GOF, gonad | Normal female | 35,2 | CAIS, Ala765Thr, negative androgen binding |
ARD557 | GOF, gonad | Normal female | 6;6 | CAIS, donor splice site exon 2/intron 2, negative androgen binding |
ARD465 | GSF, labia majora | Normal female | 5;5 | CAIS, Glu287stop, low expression of wild-type AR (Kd 0.11 nM; Bmax 3.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism) |
ARD364 | GSF, labia majora | Predominantly female | 23;0 | AIS4, Leu 172 stop, high expression of wild-type AR (Kd 0.06 nM, Bmax 22.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism) (6) |